• 1. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 2. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 3. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminobenzenesulfonamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides Aminobenzenesulfonamides

Professional Introduction to 2-(Morpholinosulfonyl)aniline (CAS No: 208643-03-2)

2-(Morpholinosulfonyl)aniline, identified by the CAS number 208643-03-2, is a significant compound in the field of chemical and pharmaceutical research. This compound belongs to a class of derivatives that exhibit unique structural and functional properties, making it a valuable subject of study in medicinal chemistry and drug development. The morpholino sulfonyl group in its molecular structure imparts specific chemical reactivity and stability, which are crucial for its potential applications in synthetic chemistry and biological assays.

The synthesis of 2-(Morpholinosulfonyl)aniline involves a series of well-defined chemical reactions that highlight the compound's versatility. The process typically begins with the reaction of aniline derivatives with sulfonylating agents, followed by the introduction of the morpholine moiety through nucleophilic substitution or other coupling reactions. The precise control of reaction conditions is essential to achieve high yields and purity, ensuring that the final product meets the stringent requirements of pharmaceutical applications.

In recent years, 2-(Morpholinosulfonyl)aniline has garnered attention for its potential role in the development of novel therapeutic agents. Its structural features make it a promising candidate for inhibiting various enzymatic targets, which are implicated in diseases such as cancer, inflammation, and neurological disorders. For instance, studies have demonstrated that derivatives of this compound can interact with specific protein kinases, modulating their activity and potentially leading to new treatment strategies.

One of the most compelling aspects of 2-(Morpholinosulfonyl)aniline is its ability to serve as a scaffold for drug design. Researchers have leveraged its unique chemical properties to develop libraries of compounds with enhanced binding affinity and selectivity. These efforts have led to the identification of several lead candidates that are currently undergoing further investigation in preclinical studies. The morpholino sulfonyl group, in particular, has been found to improve solubility and metabolic stability, which are critical factors for drug efficacy and safety.

The latest advancements in computational chemistry have also played a pivotal role in understanding the behavior of 2-(Morpholinosulfonyl)aniline. Molecular modeling techniques have allowed researchers to predict how this compound interacts with biological targets at an atomic level. These insights have not only accelerated the drug discovery process but also provided a deeper understanding of its mechanism of action. Such computational approaches are increasingly integral to modern pharmaceutical research, enabling more efficient and targeted development of new drugs.

Moreover, the environmental impact of synthesizing 2-(Morpholinosulfonyl)aniline has been a focus of recent studies. Efforts have been made to optimize synthetic routes to minimize waste and reduce energy consumption. Green chemistry principles have been applied to develop more sustainable methods for producing this compound, aligning with global initiatives to promote environmentally friendly practices in the chemical industry. These innovations highlight the compound's potential not only as a therapeutic agent but also as a model for sustainable chemical synthesis.

The future prospects for 2-(Morpholinosulfonyl)aniline are promising, with ongoing research exploring its applications in various fields. Its versatility as a building block for drug design continues to drive innovation, and new derivatives are being synthesized with improved pharmacological properties. As our understanding of biological systems grows, so too does the potential for this compound to contribute to groundbreaking therapies that address unmet medical needs.

In conclusion, 2-(Morpholinosulfonyl)aniline (CAS No: 208643-03-2) represents a significant advancement in chemical and pharmaceutical research. Its unique structural features and functional properties make it a valuable tool for developing novel therapeutic agents. With continued research and innovation, this compound is poised to play a crucial role in addressing some of the most pressing challenges in medicine today.

• 6374-97-6(3-amino-N,N-bis(2-hydroxyethyl)benzenesulfonamide)
• 21626-70-0(4-(morpholine-4-sulfonyl)aniline)
• 22184-97-0(3-(morpholine-4-sulfonyl)aniline)
• 53915-80-3(Morpholine, 4-[(4-hydrazinophenyl)sulfonyl]-)
• 783273-51-8(N-Methyl-4-(morpholinosulfonyl)benzenamine)
• 55619-44-8(4-(morpholine-4-sulfonyl)benzene-1-sulfonamide)
• 137473-58-6(Morpholine, 4-[[4-(methylamino)phenyl]sulfonyl]-, monohydrochloride)
• 18790-84-6(4-amino-n,n-bis(2-hydroxyethyl)benzenesulfonamide)
• 389605-76-9(Benzenesulfonamide, 4-amino-N-(2-methoxyethyl)-N-methyl-)
• 5033-21-6(4-(phenylsulfonyl)morpholine)